Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is the main source of extracellular pyrophosphate. Along with tissue-nonspecific alkaline phosphatase (TNAP), ENPP1 plays an important role in balancing bone mineralisation. Although well established in pre-osteoblasts, the regulating mechanisms of ENPP1 in osteoblasts and osteocytes remain largely unknown. Using bioinformatic methods, Osterix (Osx), an essential transcription factor in osteoblast differentiation and osteocyte function, was found to have five predicted binding sites on the ENPP1 promoter. ENPP1 and Osx showed a similar expression profile both in vitro and in vivo. Over-expression of Osx in MC3T3-E1 and MLO-Y4 cells significantly up-regulated the expression of ENPP1 (p < 0.05). The consensus Sp1 sequences, located in the proximal ENPP1 promoter, were identified as Osx-regulating sites using promoter truncation experiments and chromatin immunoprecipitation (ChIP) assays. The p38-mitogen-activated protein kinase (MAPK) signalling pathway was demonstrated to be responsible for ENPP1 promoter activation by Osx. Runt-related transcription factor 2 (Runx2) was confirmed to have synergistic effects with Osx in activating ENPP1 promoter. Taken together, these results provided evidence of the regulating mechanisms of ENPP1 transcription in osteoblasts and osteocytes.
Introduction
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is a type II transmembrane glycoprotein comprising two identical disulphide-bonded subunits. It is expressed in pre-osteoblasts (Nam et al., 2011) , osteoblasts and osteocytes . ENPP1 has a broad specificity and cleaves a variety of substrates, including nucleotide sugars, phosphodiester and pyrophosphate bonds (Evans et al., 1973) . Coordinating with tissue-nonspecific alkaline phosphatase (TNAP), ENPP1 generates pyrophosphate (PPi) from extracellular nucleotides (Stefan et al., 2005) . As an inhibitor of hydroxyapatite crystal formation, PPi is further hydrolysed by TNAP, releasing phosphate (Pi) and changing the Pi/PPi ratio, which is crucial for bone mineralisation (Hessle et al., 2002; Moss et al., 1967) . The function of ENPP1 in mineralisation is firstly stated in the tiptoe walking (ttw/ttw) mice, which are characterised by ectopic ossification and altered bone development (Okawa et al., 1998; Rutsch et al., 2003; Sakamoto et al., 1994) . Moreover, in a mouse model lacking ENPP1 (Enpp1 −/− ), Mackenzie et al. (2012) observe that the www.ecmjournal.org
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architecture and mineralisation of long-bones are severely disrupted. These results indicate the critical role of ENPP1 in regulating bone mineralisation homeostasis. Knowledge of the upstream mechanisms that regulate ENPP1 is essential for a better understanding of the physical process of bone mineralisation. Distalless homeobox (DLX3) inhibits ENPP1 expression during bone development (Isaac et al., 2014) . Fibroblast growth factor 2 (FGF2) can induce ENPP1 expression in pre-osteoblasts only by the mediation of osteoblast-related transcription factors, such as Msh homeobox 2 (Msx2) and runt-related transcription factor 2 (Runx2) (Hatch et al., 2009) . The regulating mechanisms in osteoblasts and osteocytes are still unknown.
Osterix (Osx), a zinc-finger-containing transcription factor, is present in all developing stages of bone and is essential for osteogenic differentiation, osteocyte maturation and function and bone mineralisation homeostasis (Nakashima et al., 2002; Zhou et al., 2010) . On one hand, Osx activates the transcription of collagen type I alpha 1 chain (Col1a1) (Nakashima et al., 2002; Zhou et al., 2010) , osteocalcin (Niger et al., 2011) and special AT-rich sequencebinding protein 2 (SATB2) (Conner and Hornick, 2013) to promote primary crystal formation and hydroxyapatite deposition. On the other hand, Osx inhibits late stage osteogenic differentiation (Yoshida et al., 2012) and activates osteopontin and sclerostin expression (Perez-Campo et al., 2016; Poole et al., 2005) to restrain bone mineralisation. These results reveal the regulatory role of Osx in bone mineralisation homeostasis by acting on a series of mineralisationrelated genes in osteoblasts and osteocytes. However, there are still no studies on Osx regulation of ENPP1 expression.
Based on these findings, the working hypothesis was that Osx could transcriptionally regulate ENPP1 in osteoblasts and osteocytes. This study showed that Osx and ENPP1 exhibited similar expression profiles both in vitro and in vivo and that over-expression of Osx could dramatically induce ENPP1 expression. Using promoter truncation and chromatin immunoprecipitation (ChIP) assays, the binding regions of Osx on the ENPP1 promoter was identified in different conditions. The p38-mitogenactivated protein kinase (MAPK) signalling pathway was shown to be involved in the process and the synergistic effects of Osx and Runx2 on the upregulation of ENPP1 expression was demonstrated.
Materials and Methods
Cell culture and osteoblastic induction MC3T3-E1 subclone 14 cell line was purchased from ATCC. MLO-Y4 cell line was purchased from JENNIO Biological Technology (Guangzhou, China). MC3T3-E1 cells were maintained in alpha modification Eagle's medium (α-MEM) (Gibco) supplemented with 10 % foetal bovine serum (FBS) (Gibco), 100 U/mL penicillin (Gibco) and 100 µg/mL streptomycin (Gibco). MLO-Y4 cells were cultured on type-I-collagen-coated plates in α-MEM with 5 % FBS, 5 % foetal calf serum (Hyclone), 100 U/ mL penicillin and 100 µg/mL streptomycin. Human bone-marrow-derived mesenchymal stem/stromal cells (hBMSCs) were isolated from three patients (one male, two females) with lumbar degenerative diseases. Briefly, bone marrow was collected from the drilled holes of the pedicle during internal fixation of the spine (Tang et al., 2011) . Informed consents for bone marrow collection were obtained from the patients. All procedures were performed in accordance with the guidance and approval of the research ethics committee of the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China (No. 2008-55) . Mononuclear cells were purified from the bone marrow by density gradient centrifugation using Ficoll-Paque™ PREMIUM (1.077; GE Healthcare) according to the manufacturer's instructions. The isolated cells were cultured in Dulbecco's modified Eagle medium (DMEM) with 4.5 g/L glucose (Gibco) and 10 % FBS. The medium was changed every 3 d. Passage 3 cells were used in the study.
To induce osteoblastic differentiation, cells were incubated in osteogenic medium (OM) or basic medium (control). The OM contained 10 mM β-glycerophosphate (Sigma-Aldrich), 50 µg/mL ascorbic acid (Sigma-Aldrich) and 1 µM dexamethasone (Sigma-Aldrich). The medium was changed every 3 d. Cells were collected at day 7, 14 and 21 after induction for further evaluation. All the experiments were independently repeated 3 times, with 3 repetitions for each condition.
Plasmids and cell transfection
Murine Osx, Runx2, mitogen-activated protein kinase kinase 6 (MKK6) and activated MKK6EE expression constructs were generated by PCR and sub-cloned into pcDNA3.1-hisC basic vector (Invitrogen). Mouse ENPP1 promoter reporter constructs from nucleotide − 2585 to + 230 (2585-pENPP1) were generated by PCR and sub-cloned into PGL-3 basic vector (Promega). 1347-pENPP1, 1031-pENPP1, 829-pENPP1, 349-pENPP1 and 280-pENPP1 were generated by restriction enzyme digestion of 2585-pENPP1. PRL-TK vector (Promega) was used as control in dual luciferase assays. The primers used for vector construction are listed in Table 1 Animal study and immunofluorescence staining 6 d postnatal C57Bl6/j mice (Medical Laboratory Animal Centre, Guangdong, China) were euthanised and the tibiae were separated after perfusion with normal saline and 4 % paraformaldehyde. After 6 h of tissue fixation in 4 % paraformaldehyde at 4 °C, specimens were washed for 3 times in phosphate buffered saline (PBS) and decalcified for 24 h at 4 °C in 10 % ethylenediaminetetraacetic acid (EDTA). After washing 3 times with PBS, specimens were infiltrated overnight in 20 % sucrose solution for dehydration. All specimens were embedded in optimal cutting temperature (OCT) compound and cut into 10 µm-thick cryosections for further immunofluorescence staining. Single plane images were acquired using Zeiss LSM-710 confocal microscope. Each experiment was repeated 3 times. Goat polyclonal antibody against ENPP1 and rabbit polyclonal antibody against Osx (ab22552; Abcam) were used at 1 : 100 dilution. Donkey anti-goat IgG (H + L) (705-605-003; Alexa Fluor ® 647) and donkey anti-rabbit IgG (H + L) (711-545-152; Alexa Fluor ® 488) (Jackson ImmunoResearch Inc.) were used at 1 : 250 dilution.
Dual-luciferase reporter assay
MC3T3-E1 cells at 90 % confluence were transfected for 4 h and cultivated in α-MEM with 10 % FBS for another 24 h. Then, the dual-luciferase reporter assays were performed using DLR™ Assay System (Promega), according to the manufacturer's instructions. PGL-3-reporter vector and PRL-TK vector were transfected at a ratio of 20 : 1. Results were considered to be valid only if the Renilla luciferase luminescent reaction was not 1,000-fold lower than the intensity of the firefly luciferase. Luminescence was detected using a Mithras LB 940 (Berthold Technologies, Oak Ridge, TN, USA). The relative luciferase activity was calculated as the ratio of firefly luciferase activity of the reporter gene plasmid/Renilla luciferase activity (internal control) of pRL-TK vector. Each assay was repeated 3 times, with technical triplicates performed.
ChIP 1 d postnatal C57Bl6/j mice were sacrificed and the posterior limbs were separated after perfusion with normal saline and cut into small pieces (1-3 mm 3 ). MLO-Y4 cells were cultured in 100 mm dishes and used for experiments at a final confluence of 70-80 %.
from PeproTech Inc. and used at a final concentration of 2 nM to induce p38-MAPK pathway activation, while SB203580 (Calbiochem) was applied at a final concentration of 10 µM to inhibit p38-MAPK pathway activation.
Real-time reverse transcription PCR (RT-qPCR)
Total RNA was extracted using TRIzol (Invitrogen) reagent according to the manufacturer's protocol. Reverse transcription was performed using SuperScript ® VILO™ cDNA Synthesis Kit (Invitrogen) according to the manufacturer's instruction. The CXF-96 detection system (Bio-Rad Laboratories) was used to conduct RT-qPCR. Gene expression of ENPP1 (Homo sapiens/Mus musculus), glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Homo sapiens/ Mus musculus) and Osx (Homo sapiens/Mus musculus) was analysed using custom-designed primers (Table  2) . Amplification was conducted for all genes using SYBR Green Master Mix (Applied Biosystems). The experiments were independently repeated 3 times, with 3 repetitions for each group and technical triplicates. CT values were averaged from triplicate samples. Then, values of individual gene were normalised to the value of the housekeeping gene GAPDH.
Western blot analysis
Western blot analysis was performed using standardised methods. Undifferentiated MC3T3-E1 cells at a confluence of 70-80 % were transfected with Osx over-expression construct or basic vector for 4 h and cultivated in α-MEM with 10 % FBS for another 24 h. 25-50 µg of protein extracted from cells were separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes. Then, membranes were blocked, immunoblotted overnight at 4 °C with relevant primary antibodies and probed 1 h at room temperature with the appropriate secondary peroxidase-conjugated antibodies. The immunoblots were visualised by enhanced chemiluminescence. Goat polyclonal antibody against ENPP1 (ab40003; Abcam) was used at a concentration of 3 µg/mL. Mouse monoclonal antibody against GAPDH (ab8245; Abcam), goat anti-mouse HRP (ab6789; Abcam) and donkey anti-goat HRP (ab6885; Abcam) were used at 1 : 10,000 dilution. The experiment was repeated 3 times. Rabbit polyclonal antibody against Osx (Abcam) was used at the concentration of 5 mg/mL and rabbit IgG (A7016; Beyotime) was used as negative control at 1 : 5000 dilution. All the primers used in ChIP assays are listed in Table 3 .
Statistical analysis
Statistical analysis was performed using SPSS 16.0 statistical software. Student's t-test and oneway ANOVA followed by Bonferroni's multiple comparison tests were utilised. Quantitative data are presented as means ± standard error of the mean (SEM). p < 0.05 was considered statistically significant. (Fig. 1a,b) . In MLO-Y4, the confocal images showed the co-expression of ENPP1 and Osx (Fig. 1c) . To explore the distribution of ENPP1 and Osx in vivo, tibiae of 6 d postnatal mice were sectioned for immunofluorescence co-staining: ENPP1 and Osx co-expressed in cortical bone and periosteum (white arrows) (Fig. 1d) .
Osx transfection up-regulated ENPP1 expression
To investigate the regulation of Osx on ENPP1 expression, the Osx over-expression construct (OverOsx) or the control vector were transfected into undifferentiated MC3T3-E1 and MLO-Y4 cells for 4 h and cultivated in α-MEM with 10 % FBS for another 24 h. RT-qPCR results showed that the mRNA expression of ENPP1 was significantly increased following the transfection (p < 0.05) (Fig. 2a,b) . Protein levels of ENPP1 and Osx were significantly increased in MC3T3-E1 cells in the Over-Osx group (p < 0.01) (Fig. 2c,d ).
Activation of ENPP1 promoter by Osx
To gain further insight into the mechanisms of ENPP1 expression regulation by Osx, a 3-kbp-long region comprising the promoter, 5' untranslated region (UTR) and coding sequence of ENPP1 were obtained from the UCSC Genome Browser (Web ref. 1) and the sequence conservation was analysed using the UCSC BLAT Search (Web ref. 2) . Results showed that the sequence was highly conserved between multiple vertebrate species (Fig. 3a) . Transcription start sites were predicted using Promoter 2.0 Prediction Server (Web ref.
3), which showed a "highly likely prediction" site starting from position −301 (Fig. 3b) . Based on the above analysis results and previous results relating to ENPP1 regulation, a 2.6-kbp-long promoter region and the entire 5' UTR sequence were chosen for further study. JASPAR core database (Web ref. 4) was used for matches of Sp1 binding matrices. The relative scores of matrices similarity were set to 0.8. As shown in Fig. 3c , 5 predicted binding sites were reported. Luciferase reporter constructs with the 2.6-kbp-long murine promoter sequence of ENPP1 were constructed for dual-luciferase reporter assays.
Results showed that Osx could significantly increase the luciferase activity in MC3T3-E1 cells transfected with 2585-pENPP1 construct when compared with 7 www.ecmjournal.org the control group transfected with PGL-3 basic vector (p < 0.01), thus demonstrating the direct activation of ENPP1 by Osx (Fig. 3d) . To further define the binding sites, promoter truncation experiments were performed. Results showed that the luciferase activity of 1347-pENPP1, 1031-pENPP1, 829-pENPP1, 349-pENPP1 and 280-pENPP1 was significantly higher than the control group (p < 0.01) and the luciferase activity was decreased after truncation of site 2 (Fig. 3d) . ChIP results showed that Osx could bind any of the 5 predicted sites with equal input of incidence in the tibiae of 6 d postnatal mice (Fig. 3e) . In MLO-Y4 cells, Osx activated ENPP1 expression by binding any of the predicted site except for site 4 (− 349 to − 340) (Fig. 3f) .
p38-MAPK pathway contributed to Osx activation of ENPP1 promoter Next, the question whether p38 kinase was involved in Osx regulation of ENPP1 activation in undifferentiated MC3T3-E1 was explored. Both the expression of Osx (Fig. 4a) and ENPP1 (Fig. 4b) were significantly increased by 24 h treatment with bone morphogenic protein 2 (BMP-2), which was abolished by the p38 inhibitor SB203580 (p < 0.05). Similarly, treatment with SB203580 inhibited Osx (Fig. 4c) and ENPP1 (Fig.  4d ) expression in the Osx over-expressing condition (p < 0.05). To further confirm the relevance of p38 in the regulation, the constitutive active MKK6 mutant expressional construct (MKK6EE) was transfected into MC3T3-E1 cells for 4 h and cultivated in α-MEM 9 www.ecmjournal.org with 10 % FBS for another 24 h to activate p38-MAPK pathway (Han et al., 1996; Raingeaud et al., 1996) . RTqPCR results showed that ENPP1 was significantly increased after delivery of MKK6EE (Fig. 4e) . The expression of ENPP1 was the highest with both Osx and MKK6EE over-expression (Fig. 4f ).
Runx2 showed synergistic transcriptional effects with Osx
To explore the synergistic transcriptional regulation effect of Osx and Runx2 on ENPP1, the overexpression constructs were separately or cotransfected into MC3T3-E1 cells. The co-transfection group significantly increased ENPP1 expression as compared with the individual transfection groups (p < 0.05) (Fig. 5a ). This result was confirmed by the dual-luciferase reporter assay (Fig. 5b) .
Discussion
ENPP1 plays a crucial role in bone mineralisation. Previous studies have explored the regulating mechanisms of ENPP1 in pre-osteoblasts. However, its role in osteoblasts and osteocytes remains unclear.
In the current study, the expression pattern of ENPP1 and Osx in vitro and in vivo was screened and the direct activation of ENPP1 promoter by Osx was demonstrated. The regulation sites were confirmed using promoter truncation experiments and ChIP assays. p38-MAPK signalling pathway was shown to contribute to the regulation process. Finally, the synergistic effects of Osx and Runx2 on the activation of ENPP1 expression were identified.
Exploring the distribution pattern of ENPP1 expression can help the understanding of its regulating mechanisms. In vitro, the expression of ENPP1 was investigated using MC3T3-E1 cells and hBMSCs during osteogenic differentiation. MC3T3-E1 is a calvaria-derived pre-osteoblast cell line that can differentiate into mature osteoblasts after 21 d of osteogenic cultivation (Mc et al., 2016; Ma et al., 2017) . hBMSCs are widely used in osteogenesis research and can be induced into osteoblast-lineage cells and finally mature osteoblasts after 21 d of osteogenic cultivation (Bertram et al., 2005; Cooper et al., 2001; D' Ippolito et al., 1999) . ENPP1 exhibited continuously high expression in the osteogenic conditions, similarly to Osx. The MLO-Y4 osteocyte cell line was established by Kato et al. in 1997 . With very similar properties to primary osteocytes (Bonewald et al., 1999; Kato et al., 1997) , MLO-Y4 cells are commonly used in osteocyte-related studies (Mattinzoli et al., 2012; Rosser and Bonewald et al., 2012; Yin et al., 2014) . In the current study, ENPP1 was expressed in MLO-Y4 cells, as shown in previous studies (Kyono et al., 2012; Turner et al., 2014) . In addition, a high-level of co-expression of ENPP1 with Osx was detected in MLO-Y4, as measured by confocal microscopy. These results suggested that ENPP1 was activated during the osteoblast differentiation and maturation process and in osteocytes. In vivo results showed co-distribution of ENPP1 and Osx in cortical bone and periosteum of 6 d postnatal mice. During development and regeneration, periosteum-derived stem cells and progenitor cells transfer or migrate to cortical bone to differentiate into osteoblasts and finally osteocytes (Ferretti and Mattioli-Belmonte et www.ecmjournal.org MM Gao et al. Osterix regulates ENPP1 al., 2014; Hvid et al., 2016) . Both in vitro and in vivo data showed similar expression pattern of ENPP1 and Osx in osteoblasts and osteocytes, suggesting the potential relationship between these two genes. Several studies focus on the effects and mechanisms of FGF2 regulation on ENPP1 expression (Hatch et al., 2005; Hatch et al., 2009; . These studies show that FGF2 can induce Runx2 and Msx2-mediated ENPP1 expression in pre-osteoblasts. However, both Runx2 and Msx2 are down-regulated in osteoblasts and FGF2 can no longer stimulate ENPP1 expression. Although FGF2 induces ENPP1 expression in osteocytes in an extracellular-signalregulated kinase (ERK)-MAPK-dependent manner (Kyono et al., 2012) , Runx2 and Msx2 hardly play regulatory roles, with little expression in osteocytes. These results imply that there are other regulating mechanisms in osteoblasts and osteocytes. As the essential transcription factor regulating osteoblast differentiation, osteocyte function and bone mineralisation homeostasis, the role of Osx in regulating ENPP1 was the focus of the current study. The current study demonstrated that ENPP1 could be directly activated by Osx in osteoblasts and osteocytes, indicating a new regulating mechanism of ENPP1 transcription. Besides ENPP1, Osx regulates several bone-mineralisation-related genes, including Col1a1 (Ortuno et al., 2013) , osteocalcin (Niger et al., 2011) , SATB2 (Conner and Hornick, 2013) , osteopontin and sclerostin (Poole et al., 2005) . It should be noted that among these genes, some promote bone mineralisation, some serve as inhibitors and some show bidirectional roles, such as ENPP1. Therefore, Osx acts as a coordinator to guide normal bone mineralisation. Either dysfunction or over-expression of Osx could lead to abnormal bone mineralisation (Zhou, et al., 2010) . p38-MAPK is one of the most critical pathways regulating osteogenic differentiation and mineralisation (Greenblatt et al., 2010; Hu et al., 2003) . During osteogenesis, p38 is crucial for activating Osx (Ortuno et al., 2010; Wang et al., 2007) and it is involved in the transcription regulation of Osx on target genes (Ortuno et al., 2013) . The results of the current study demonstrated that p38 contributed to the activation of ENPP1 by Osx. Interestingly, PPi, the primary product of ENPP1, can in turn induce p38-MAPK pathway to increase osteopontin expression, which restrains the mineralisation process (Ortuno et al., 2010) . In addition to p38, ERK1/2 is another important kinase that regulates Osx (Choi et al., 2011) . However, previous studies show variable results regarding ERK1/2 regulation of Osx, as well as ENPP1, in different conditions. Xiao et al. (2013) report that in MSCs, activation of ERK-MAPK signalling pathway inhibits Osx expression, leading to impaired osteogenesis and abnormal mineralisation. On the contrary, Byun et al. (2014) show that activating ERK-MAPK pathway can stimulate MSCs osteogenic differentiation by activating Osx. Similarly to the debated effect on Osx, ERK1/2 regulation of ENPP1 expression is also not clearly definite. In osteocytes, FGF2 can up-regulate ENPP1 in an ERK-MAPK-dependent manner (Kyono et al., 2012) , whereas FGF2 has no effect on ENPP1 expression in osteoblasts, suggesting that the effects of ERK1/2 on ENPP1 expression are different from osteoblasts to osteocytes. However, the results of the present study showed that Osx regulated ENPP1 expression in both osteoblasts and osteocytes, suggesting that ERK1/2 may not be a key player in contributing to Osx activation of ENPP1 expression.
In the promoter truncation experiments, the luciferase activity decreased after truncation of the two proximal binding sites, indicating that the secondary proximal binding site might have the highest activity. The luciferase activity was still much higher than the control group after truncation of all the 5 predicted binding sites, suggesting that Osx could activate ENPP1 expression by binding to the left sequence, most of which belonged to 5' UTR. The 5' UTR functions as a regulatory element in some genes (Bonnet-Magnaval et al., 2016; Drissi et al., 2000; Guo and Lu et al., 2017) . More work should be carried out to identify the regulatory elements in the 5' UTR of ENPP1.
The ChIP assays, using bone specimens of 6 d postnatal mice, confirmed that Osx could bind any of the 5 predicted binding sites, which confirmed the promoter truncation experiments. The specific function of each binding site, as well as the interaction between them, should be further investigated. In the present study, mice tibiae were utilised for ChIP assays to reflect the in vivo situation. However, the effective input of each binding site should be calculated as the average of the different cell types utilised. In MLO-Y4 osteocyte cell line, results of ChIP assays showed that Osx could not bind the site 4 (− 349 ~ − 340) of ENPP1 promoter, suggesting a cell-specific regulating mechanisms. To identify the regulating mechanisms in the specific cell stage, more detailed studies should be carried out in the future.
Osx has synergistic roles with Runx2 in the activation of several target genes, such as Col1a1 (Artigas, et al., 2014; Ortuno, et al., 2013) , Fmod and Ibsp (Artigas, et al., 2014) . Runx2 activates ENPP1 promoter in pre-osteoblasts and the proximal binding sites are close to Osx binding sites (Hatch, Li and Franceschi, 2009 ). For these reasons, the synergistic roles of these two transcription factors in activating ENPP1 promoter were explored. The results showed that Osx and Runx2 had additive effects on ENPP1 promoter activation. Moreover, although ENPP1 was regulated by different mechanisms at various stages of differentiation, the two key factors were closely correlated with each other.
Conclusion
Osx, a key transcriptional factor in osteoblasts and osteocytes, significantly activated ENPP1 www.ecmjournal.org transcription. Different conditions affected Osx binding to its 5 binding sites on the ENPP1 promoter. The p38-MAPK pathway contributed to this regulatory process. In addition, Runx2 showed synergistic roles with Osx in activating ENPP1 expression. This was the first description of the regulating mechanisms of ENPP1 expression in osteoblasts and osteocytes.
